Prev Arrow Stocks

Corteva Inc. ($CTVA) Stock Forecast: Up 2.1% Today

Morpher AI identified a bullish signal. The stock price may continue to rise based on the momentum of the good news.

What is Corteva Inc.?

Corteva Inc. (CTVA) is a leading agricultural chemical company focused on providing innovative solutions for weed control in corn and soybean markets in North and South America.

Why is Corteva Inc. going up?

CTVA stock is up 2.1% on Jun 18, 2026 19:46

  • CTVA stock saw a rise today due to the announcement of a co-exclusive supply and license agreement with FMC Corporation for rimisoxafen herbicide technology.
  • The partnership aims to strengthen CTVA's weed-control products, offering better options for handling herbicide-resistant weeds in important agricultural markets.
  • Corteva's substantial prepayment to FMC reflects a dedication to innovation and strategic expansion, likely increasing investor confidence in the company's future prospects.
  • This optimistic market outlook is also supported by Corteva's emphasis on innovation and restructuring efforts, suggesting a potential shift towards operational efficiency and enhanced competitiveness within the industry.

CTVA Price Chart

CTVA Technical Analysis

CTVA News

FMC and Corteva Partner to Expand Access to Rimisoxafen Technology

FMC Corporation and Corteva, Inc. have formed a co-exclusive strategic supply and license agreement to broaden the availability of FMC's rimisoxafen herbicide technology across North and South America. This partnership aims to provide improved solutions for managing herbicide-resistant weeds in corn and soybean markets. Corteva will make an initial prepayment of $200 million, and both companies will independently develop and commercialize exclusive formulations of the dual-mode-of-action herbicide.

https://sg.finance.yahoo.com/news/fmc-corteva-partner-expand-access-160700573.html

0 News Article Image FMC and Corteva Partner to Expand Access to Rimisoxafen Technology

Mission Produce's Valuation Looks Expensive: Buy Now or Wait?

Mission Produce (AVO) stock appears overvalued with a P/E multiple of 16.67X, exceeding the industry average, despite strategic initiatives and strong volume growth. While near-term profitability was impacted by an unusually high avocado supply and lower prices, the company's long-term growth potential

https://www.tradingview.com/news/zacks:87858c722094b:0-mission-produce-s-valuation-looks-expensive-buy-now-or-wait/

1 News Article Image Mission Produce's Valuation Looks Expensive: Buy Now or Wait?

What Corteva (CTVA)'s Rimisoxafen Deal With FMC Means For Shareholders

Corteva has secured a co-exclusive supply and license agreement with FMC for rimisoxafen herbicide technology, enhancing its weed-control portfolio for corn and soybean markets in North and South America. This deal, including a significant prepurchase commitment, supports Corteva's innovation-led strategy and restructuring efforts, despite the long-term nature of its impact on earnings. The article advises investors to consider the company's focus on cost-cutting and potential fair value discrepancies.

https://simplywall.st/stocks/us/materials/nyse-ctva/corteva/news/what-corteva-ctvas-rimisoxafen-deal-with-fmc-means-for-share/amp

2 Missing News Article Image What Corteva (CTVA)'s Rimisoxafen Deal With FMC Means For Shareholders

What Corteva (CTVA)'s Rimisoxafen Deal With FMC Means For Shareholders

Corteva Inc. announced a co-exclusive supply and license agreement with FMC Corporation for rimisoxafen herbicide technology, enhancing Corteva's weed-control portfolio. This deal, while reinforcing Corteva's innovation narrative and supporting its restructuring efforts, will not impact sales until near the end of the decade, meaning investors must weigh long-term benefits against immediate earnings volatility and ongoing competitive pressures. The company's future performance hinges on its ability to streamline operations and integrate new technologies effectively.

https://simplywall.st/stocks/us/materials/nyse-ctva/corteva/news/what-corteva-ctvas-rimisoxafen-deal-with-fmc-means-for-share

3 News Article Image What Corteva (CTVA)'s Rimisoxafen Deal With FMC Means For Shareholders

Intrepid Potash Inc (IPI) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Intrepid Potash Inc (IPI), detailing its current earnings forecast score, analyst ratings, and price targets. It highlights that the company ranks 60 out of 68 in the Chemicals industry and that analysts predominantly recommend a "Sell" for the stock, with a target price of $23.00. The report also includes expected revenue for the next quarter and recent EPS performance against market expectations.

https://www.tradingkey.com/markets/stocks/nasdaq-ipi/earnings

4 News Article Image Intrepid Potash Inc (IPI) Earnings Forecast: Future EPS & Revenue Growth Estimates

Corteva Inc. Price History

05.00.2026 - CTVA Stock was down 0.1%

  • The bearish movement in CTVA's stock today could be attributed to several factors:
  • Despite reporting a strong quarter with revenue growth and an EPS beat, the market may have reacted negatively to potential concerns about future growth prospects.
  • The increased stake by Generali Asset Management SPA SGR and TriaGen Wealth Management LLC could have led to profit-taking by other investors, causing a temporary dip in the stock price.
  • The focus on FMC Corp.'s innovative agricultural technology and its potential to disrupt the industry may have shifted investor sentiment away from Corteva, impacting its stock performance.
  • The updates in Platts Industrial Materials Index, while not directly related to CTVA, could have influenced overall market trends and contributed to the bearish movement in the stock.

05.01.2026 - CTVA Stock was down 5.2%

  • The company was downgraded from an "overweight" to a "neutral" rating by a major financial institution. This downgrade included a new price target of $77.00, impacting the stock in a negative way.
  • Corteva's Q4 earnings were a mix of meeting EPS estimates but falling short on revenue. This revenue miss, coming in at $3.91 billion instead of the expected $4.24 billion, led to selling pressure on the stock.
  • Despite the downgrade and revenue shortfall, Corteva raised its FY 2026 EPS guidance, showing optimism for future growth. This optimistic forecast may help stabilize the stock in the short term.
  • The decrease in stake by a notable investment management firm and the overall pattern of analyst downgrades, transitioning from positive to neutral ratings, are also influencing factors in the bearish market performance of Corteva today.

05.10.2025 - CTVA Stock was up 3.5%

  • CTVA stock saw significant upward momentum today, possibly fueled by positive expectations surrounding its Q3 earnings.
  • Increased avocado volumes from Peru and Mexico hint at a positive trend in the agricultural industry, which could bode well for companies like Corteva, Inc.
  • While Mission Produce's profitability may have been impacted by lower avocado prices, this could have indirectly lowered input costs for CTVA's agricultural offerings.
  • Optimism about CTVA's future performance in the upcoming quarter has led to heightened investor interest, driving up the stock price.

18.05.2026 - CTVA Stock was up 2.1%

  • CTVA stock saw a rise today due to the announcement of a co-exclusive supply and license agreement with FMC Corporation for rimisoxafen herbicide technology.
  • The partnership aims to strengthen CTVA's weed-control products, offering better options for handling herbicide-resistant weeds in important agricultural markets.
  • Corteva's substantial prepayment to FMC reflects a dedication to innovation and strategic expansion, likely increasing investor confidence in the company's future prospects.
  • This optimistic market outlook is also supported by Corteva's emphasis on innovation and restructuring efforts, suggesting a potential shift towards operational efficiency and enhanced competitiveness within the industry.

06.00.2026 - CTVA Stock was up 1.8%

  • The company unveiled its fourth-quarter 2025 earnings along with a live webcast, showcasing transparency and investor engagement. This action likely increased market confidence in Corteva.
  • Despite financial challenges like a low Return on Equity (ROE), the initiation of a new position by TriaGen Wealth Management LLC and favorable analyst ratings could have bolstered the positive market sentiment.
  • Corteva's strategic expansions through joint ventures and new product introductions, combined with a robust quarter performance showing a 6.5% revenue increase year-over-year, might have further fueled investor confidence.
  • The company's emphasis on innovative and sustainable agricultural solutions in line with industry trends could have also played a role in the positive movement of Corteva's stock.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.